| Literature DB >> 26857734 |
Yayun Gu1, Chengxiao Yu1, Limin Miao2, Lihua Wang1, Chongquan Xu1, Wenjie Xue1, Jiangbo Du1, Hua Yuan1,2, Juncheng Dai1,3, Guangfu Jin1,3, Zhibin Hu1,3, Hongxia Ma1,3, Hongbing Shen1,3.
Abstract
Telomere dysfunction participates in malignant transformation and tumorigenesis. Previous studies have explored the associations between telomere length (TL) and cancer susceptibility; however, the findings are inconclusive. The associations between genetic variants and TL have been verified by quite a few genome-wide association studies (GWAS). Yet, to date, there was no published study on the relationship between TL, related genetic variants and susceptibility to squamous cell carcinoma of the head and neck (SCCHN) in Chinese. Hence, we detected relative telomere length (RTL) by using quantitative PCR and genotyped seven selected single nucleotide polymorphisms by TaqMan allelic discrimination assay in 510 SCCHN cases and 913 controls in southeast Chinese. The results showed that RTL was significantly associated with SCCHN risk [(adjusted odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.08-1.32, P = 0.001]. Furthermore, among seven selected SNPs, only G allele of rs2736100 related to RTL in Caucasians was significantly associated with both the decreased RTL (P = 0.002) and the increased susceptibility to SCCHN in Chinese (additive model: adjusted OR = 1.17, 95%CI = 1.00-1.38, P = 0.049). These findings provide evidence that shortened TL is a risk factor for SCCHN, and genetic variants can contribute to both TL and the susceptibility to SCCHN in southeast Chinese population.Entities:
Mesh:
Year: 2016 PMID: 26857734 PMCID: PMC4746643 DOI: 10.1038/srep20675
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of the subjects in this study.
| Variable | N (%) | ||
|---|---|---|---|
| Controls(n = 913) | Cases(n = 510) | ||
| Age at diagnosis (years) | |||
| Mean ± SD, y | 59.78 ± 9.37 | 61.28 ± 10.72 | 0.440 |
| <60 | 433(47.43) | 231(45.29) | |
| ≥60 | 480(52.57) | 279(54.71) | |
| Sex | |||
| Male | 682(74.70) | 357(70.00) | 0.056 |
| Female | 231(25.30) | 153(30.00) | |
| Smoking status | |||
| Never | 451(49.40) | 249(49.02) | 0.890 |
| Ever | 462(50.60) | 259(50.98) | |
| Drinking status | |||
| Never | 574(62.87) | 255(50.10) | 0.001 |
| Ever | 339(37.13) | 254(49.90) | |
| Tumor site | |||
| Oral | − | 403(79.02) | |
| Others | − | 107(20.98) | |
aTwo-sided Chi-square test.
bThe smoking and drinking status were unavailable for two and one controls, respectively.
Distributions of relative telomere length (RTL) among controls.
| Selected variables | N | RTL, mean(95%CI) | |
|---|---|---|---|
| Age at diagnosis (years) | |||
| <60 | 433 | 1.61(1.58–1.66) | |
| ≥60 | 480 | 1.40(1.37–1.44) | |
| Sex | |||
| Male | 682 | 1.48(1.45–1.51) | |
| Female | 231 | 1.56(1.51–1.62) | |
| Smoking status | |||
| Never | 451 | 1.51(1.48–1.55) | 0.569 |
| Ever | 462 | 1.50(1.46–1.53) | |
| Drinking status | |||
| Never | 574 | 1.52(1.48–1.55) | 0.232 |
| Ever | 339 | 1.49(1.44–1.53) | |
aTwo-sided t test.
Association between relative telomere length (RTL) and SCCHN risk.
| Quartiles | RTL | Controls | Cases | Adjusted OR(95%CI) | |
|---|---|---|---|---|---|
| 75%~ | ≥1.81 | 228(24.97) | 98(19.22) | 1 | |
| 50% ~ 75% | 1.51–1.81 | 228(24.97) | 98(19.22) | 1.03(0.73–1.45) | 0.864 |
| 25% ~ 50% | 1.22–1.51 | 228(24.97) | 157(30.78) | 1.58(1.15–2.17) | |
| ~25% | <1.22 | 229(25.09) | 157(30.78) | 1.56(1.13–2.15) | |
| Trend | − | − | − | 1.19(1.08–1.32) |
aDerived from logistic regression with an adjustment for age at blood collection, sex, smoking and drinking status.
Associations of the reported loci with relative telomere length (RTL) among controls.
| Loci | Chr. | Gene | Alleles | Call rate (%) | MAF | β | |
|---|---|---|---|---|---|---|---|
| rs10936599 | 3q26.2 | T/C | 98.1 | 0.465 | −0.022 | 0.370 | |
| rs11125529 | 2p16.2 | C/A | 98.6 | 0.214 | 0 | 0.991 | |
| rs2736100 | 5p15.33 | T/G | 98.2 | 0.419 | −0.060 | ||
| rs4387287 | 10q24.33 | A/C | 96.1 | 0.160 | −0.002 | 0.956 | |
| rs755017 | 20q13.33 | A/G | 93.8 | 0.443 | −0.002 | 0.924 | |
| rs7675998 | 4q32.2 | A/G | 98.4 | 0.187 | −0.029 | 0.356 | |
| rs8105767 | 19p12 | A/G | 98.5 | 0.289 | −0.046 | 0.088 |
aEffect allele/alternative allele; effect allele is one associated with short telomeres, corresponding to the negative value of β estimates.
bMinor allele frequency among controls in this study.
cDerived from generalized linear models with an adjustment for age at blood collection and sex.
Associations between rs2736100 and SCCHN risk.
| Gene | SNP | Controls | Cases | Adjusted OR (95%CI) | |
|---|---|---|---|---|---|
| N (%) | N (%) | ||||
| rs2736100 | 897 | 495 | |||
| TT | 317(35.3) | 144(29.1) | 1 | ||
| TG | 419(46.7) | 255(51.5) | 1.37(1.06–1.78) | ||
| GG | 161(18.0) | 96(19.4) | 1.32(0.95–1.83) | 0.099 | |
| TG + GG | 580(64.7) | 351(70.9) | 1.11(1.02–1.20) | ||
| Additive model | 1.17(1.00–1.38) |
aGenotypes were available from 495 cases and 897 controls
bDerived from logistic regression with an adjustment for age, sex, smoking and drinking status.
Figure 1Meta-analysis of associations between telomere length and risk of SCCHN.